|Date of loan:||28 Feb 2017|
|Amount in EUR:||EUR 40 million|
|NACE sector / loan type:||Research and development|
|Industries and services|
The loan has been provided to co-finance Valio’s research and development costs for 2016–2020.
The R&D programme focuses on developing new products. Valio aims to add value to its assortment and to deliver benefits to its milk producers and consumers.
Valio Ltd. is Finland’s largest dairy company and sells products in about 60 countries. The company is owned by 17 dairy cooperatives and operates one of the largest private research laboratories in Finland. Valio is headquartered in Helsinki.
The intensity of Valio’s R&D has developed substantially over the past decade, and the company has a strong track record of commercialising its research. The R&D programme is expected to increase Valio’s nutritional expertise and consumer insight. A high number of on-going R&D projects are focusing on new products with positive health impacts.
The research conducted by Valio aims to promote sustainable resource consumption, such as the use of renewable bioplastics for packaging. Valio is also participating in agricultural research projects aiming for more efficient use of resources. In the long term, Valio’s R&D is expected to have a positive effect on the environmental impact of dairy farming.
No significant environmental benefits or risks have been identified related to the R&D programme.
A new loan to Klaipedos Nafta AB will finance building an LNG reloading station and extending an oil terminal in Lithuania to further boost the security of energy supply to the Baltic countries.
28 Apr 2017
A loan to the Swedish property developer Akademiska Hus AB will co-fund the construction of four university facilities across Sweden.
3 Apr 2017
A loan to the Swedish medical equipment solutions provider Elekta AB will finance R&D costs for the development of new cancer treatment solutions.
29 Mar 2017